期刊文献+

燕树勋教授从痰气论治甲状腺癌术后经验探析 被引量:18

Prof. Yan Shuxun's Experiences in the Postoperative Treatment of Thyroid Cancer Based on Phlegm and Qi Theory
下载PDF
导出
摘要 燕树勋教授系国家中医药管理局首批中医学术流派-湖北陈氏中医瘿病(甲状腺病)学术流派主要传承人,从事中医瘿病学临床、科研和教学工作20余年,具有深厚的中医理论知识和丰富的临床经验,尤其对甲状腺癌的诊疗有独到之处。甲状腺癌和甲状腺癌术后均属于中医"瘿瘤""石瘿"的范畴,燕教授认为甲状腺癌术后的病因有肝气郁结、饮食失调、起居失常、体质因素、水土因素、手术损伤、碘及激素治疗等,病机为本虚标实,标实以气郁、痰阻、血瘀、热毒为主,本虚包括气血阴阳俱虚。其中主要常见病机为气郁、痰阻,临床症候以气郁痰阻多见,治疗从痰气论治,以理气化痰为主,采用柴胡疏肝散合二陈汤加减,取得了满意的临床疗效。 Prof. Yan Shuxun is the inheritor of the academic school for the treatment of goiter,approved by the State Administration of Traditional Chinese Medicine. Prof. Yan has been engaged in clinical practice,scientific research and education of goiter in TCM for over 20 years and has accumulated rich experiences in clinical work and TCM theories,especially for the unique treatment of goiter. Thyroid cancer and the postoperative condition of it are in the category of yingliu or shiliu in TCM. Prof. Yan believes that the postoperative disorder of goiter is related to liver qi stagnation,improper diet and living habit,constitutional factors,geographic factors,surgical injury,iodine and hormone treatment in etiology. The pathogenesis refers to the deficiency of the root course and excess of the secondary. The excess of the secondary indicates qi stagnation,phlegm obstruction,blood stagnation and heat toxin. The deficiency of the root cause refers to deficiency of qi,blood,yin and yang. Qi stagnation and phlegm obstruction are the most common in clinic,which should be treated with modified chaihu shugan san and er chen tang on the base of phlegm qi theory by regulating qi and resolving phlegm. The satisfactory clinical therapeutic effects are achieved.
出处 《世界中西医结合杂志》 2017年第12期1676-1679,共4页 World Journal of Integrated Traditional and Western Medicine
基金 国家中医药管理局湖北陈氏瘿病学术流派传承工作室 河南省科技创新杰出人才(174100510022) 河南中医药大学科技创新团队项目资助
关键词 燕树勋 甲状腺癌 术后 从痰气论治 专家经验 Yah Shuxun Thyroid Cancer Postoperation Treatment Based on Phlegm and Qi Theory Expert' s Experiences
  • 相关文献

参考文献10

二级参考文献30

  • 1郑冬梅,鹿宁,陈青,张海清,姜秀云,管庆波,赵家军.甲状腺结节的临床分析[J].山东大学学报(医学版),2009,47(8):14-17. 被引量:31
  • 2张秀娟,黄滨南,曲中原.小柴胡汤抗肿瘤作用研究进展[J].中国微生态学杂志,2004,16(6):382-383. 被引量:8
  • 3赵进喜,邓德强,王新歧.甲状腺疾病相关中医病名考辨[J].陕西中医学院学报,2005,28(4):1-3. 被引量:38
  • 4黄守清,邱汉平.甲状腺结节微钙化与中医瘿瘤痰瘀内结证的相关研究[J].福建中医学院学报,2007,17(4):1-2. 被引量:3
  • 5Megan RH, Daniel JR, Glen EL, et al.Higher serum thyroid stimulating horm one level in thyroid nodule patients is asso- ciated with greater risks of differentiated thyroid cancer and advanced tumor stage [J]. J C lin Endocrinol Metab, 2008, 93(3): 809-814.
  • 6Boelaert K, Horacek J, Holder RL, et al. Serum thyrotrop in concentration as a novel predictor of malignancy in thyroid nodules investigated by fineneedle aspiration [J].J C lin En- docrinol Metab, 2006,91 ( 11 ) : 4295-4301.
  • 7Samadi A, Loo P, Mukerji R, et al. A novel HSP90 Modula- tor with selective activity against thyroid cancers in vitro [ J ]. Surgery, 2009,146 (6) : 1196-1207.
  • 8Carayon P, Thomas-Morvan C, Castanas E, et al. Human thyroid cancer: membrane thyrotropin binding and adenyl- ate cyclase activity [J ]. J C lin Endocrinol Metab, 1980, 51(4): 915-920.
  • 9Mazzamerri EL, Robbins R J, Spencer CA, et al. A consen- sus report of the role of serum thyroglobulin as a monitor- ing method for low-risk patients with papillary thyroid car- cinoma [J].J Clin Endocrinol Metab, 2003,88 (4): 1433-1441.
  • 10Koyno Y, Taruani. Monoclonal antibodies to thyroglobulin elucidate differences in protein structure of thyroglobulin in healthy individuals and those with papillary adenocarci- noma[J ]. J Clin EndncrinolMetab, 1988,61:343.

共引文献79

同被引文献234

引证文献18

二级引证文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部